Download PDF
Endoscopy 2000; 32(2): 108-117
DOI: 10.1055/s-2000-88
State-of-the-Art Review
Georg Thieme Verlag Stuttgart ·New York

Ulcers and Gastritis

G. N. J. Tytgat
  • Academic Medical Center, Dept. of Gastroenterology and Hepatology, Amsterdam, The Netherlands
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

Once again this year, developments in the field of ulcers and gastritis have been entirely dominated by findings relating to Helicobacter pylori. However, interest in H. pylori can be expected to decline, since the prevalence of the infection is rapidly decreasing in the developing world - to the point that many gastroduodenal ulcers are now unrelated to H. pylori A further reason for declining interest is disappointment regarding the role of H. pylori in dyspepsia. The expected reduction in the endoscopic workload produced by screening for H. pylori or cagA positivity has so far not occurred. The exact role of the damage caused by nonsteroidal anti-inflammatory drugs in H. pylori-infected stomachs remains controversial. Equally controversial is the magnitude of the increased reflux symptomatology and reflux disease observed after H. pylori infection has been cured in patients with ulcer disease. Eradication therapy is largely dominated by proton-pump inhibitor triple therapies, although the efficacy of these is declining. Bismuth triple therapy and quadruple therapy continue to be valid alternatives.

References (Key References are highlighted)

  • 1 Blaser  M J. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. .  J Infect Dis. 1999;  179 1523-1530
    CrossrefPubMedGoogle Scholar
  • 2 Van Doorn L J, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori.  Gastroenterology. 1998;  115 58-66
    PubMedGoogle Scholar
  • 3 Van Doorn  L J, Figueiredo C, Mégraud F, et al. Geographic distribution of vacA allelic types of Helicobacter pylori. .  Gastroenterology. 1999;  116 823-830
    PubMedGoogle Scholar
  • 4 Basso D, Navaglia F, Brigato L, et al. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases.  Gut. 1998;  43 182-186
    PubMedGoogle Scholar
  • 5 Rudi J, Rudy A, Maiwald M, et al. Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases.  Am J Gastroenterol. 1999;  94 1525-1531
    CrossrefPubMedGoogle Scholar
  • 6 Sato T, Fujino M A, Kojima Y, et al. Endoscopic urease sensor system for detecting Helicobacter pylori on gastric mucosa.  Gastrointest Endosc. 1999;  49 32-38
    PubMedGoogle Scholar
  • 7 Gur G, Boyacioglu S, Demirhan B, et al. The importance of increasing the number of gastric biopsies in the diagnosis of Helicobacter pylori.  Hepatogastroenterology. 1998;  45 2219-2223
    PubMedGoogle Scholar
  • 8 Sheu B S, Lin X Z, Yang H B, Chien C H, et al. Cardiac biopsy of stomach may improve the detection of H. pylori after dual therapy.  Hepatogastroenterology. 1999;  46 543-548
    PubMedGoogle Scholar
  • 9 Chey W D, Murthy U, Shaw S, et al. A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial.  Am J Gastroenterol. 1999;  94 1512-1516
    CrossrefPubMedGoogle Scholar
  • 10 Cohen H, Rose S, Lewin D N, et al. Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test for diagnosis of Helicobacter pylori.  Helicobacter. 1999;  4 49-53
    CrossrefPubMedGoogle Scholar
  • 11 Asante M A, Mendall M A, Finlayson C, et al. Screening dyspeptic patients for Helicobacter pylori prior to endoscopy: laboratory or near-patient testing?.  Eur J Gastroenterol Hepatol. 1998;  10 843-846
    PubMedGoogle Scholar
  • 12 Chey W D, Murthy U, Toskes P, et al. The 13C urea blood test accurately detects active Helicobacter pylori infection: a United States, multicenter trial.  Am J Gastroenterol. 1999;  94 1522-1524
    CrossrefPubMedGoogle Scholar
  • 13 Cutler A F, Toskes P. Comparison of 13C urea blood test to 13C urea breath test for the diagnosis of Helicobacter pylori.  Am J Gastroenterol. 1999;  94 959-961
    CrossrefPubMedGoogle Scholar
  • 14 Breslin N P, Lee J, Buckley M, O'Morian C. Screening for Helicobacter pylori in young dyspeptic patients referred for investigation: endoscopy for those who test negative.  Aliment Pharmacol Ther. 1998;  12 577-582
    CrossrefPubMedGoogle Scholar
  • 15 Heaney A, Collins J S, Tham T C, et al. A prospective study of the management of the young Helicobacter pylori-negative dyspeptic patient: can gastroscopies be saved in clinical practice?.  Eur J Gastroenterol Hepatol. 1998;  10 953-956
    PubMedGoogle Scholar
  • 16 Asante M A, Mendall M, Patel P, et al. A randomized trial of endoscopy vs. no endoscopy in the management of seronegative Helicobacter pylori dyspepsia.  Eur J Gastroenterol Hepatol. 1998;  10 983-989
    PubMedGoogle Scholar
  • 17 Wiklund I, Glise H, Jerndal P, et al. Does endoscopy have a positive impact on quality of life in dyspepsia?.  Gastrointest Endosc. 1998;  47 449-454
    PubMedGoogle Scholar
  • 18 Laheij R J, Severens J L, Van de Lisdonk E H, et al. Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis.  Aliment Pharmacol Ther. 1998;  12 1249-1256
    CrossrefPubMedGoogle Scholar
  • 19 Nishikawa J, Kawai H, Takahashi A, et al. Seroprevalence of immunoglobulin G antibodies against Helicobacter pylori among endoscopy personnel in Japan.  Gastrointest Endosc. 1998;  48 237-243
    PubMedGoogle Scholar
  • 20 Meineche-Schmidt  V, Christensen E. Classification of dyspepsia: identification of independent symptom components in 7270 consecutive, unselected dyspepsia patients from general practice.  Scand J Gastroenterol. 1998;  33 1262-1272
    CrossrefPubMedGoogle Scholar
  • 21 Bamfi F, Olivieri A, Arpinelli F, et al. Measuring quality of life in dyspeptic patients - development and validation of a new specific health status questionnaire: final report from the Italian QPD project involving 4000 patients.  Am J Gastroenterol. 1999;  94 730-738
    PubMedGoogle Scholar
  • 22 Talley  N J, Haque M, Wyeth J W. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index.  Aliment Pharmacol Ther. 1999;  13 225-235
    CrossrefPubMedGoogle Scholar
  • 23 Rothenbacher D, Peter R, Bode G, et al. Dyspepsia in relation to Helicobacter pylori infection and psychosocial work stress in white collar employees.  Am J Gastroenterol. 1998;  93 1443-1449
    CrossrefPubMedGoogle Scholar
  • 24 Stone M A, Barnett D B, Mayberry J F, et al. Lack of correlation between self-reported symptoms of dyspepsia and infection with Helicobacter pylori in a general population sample.  Eur J Gastroenterol Hepatol. 1998;  10 301-304
    PubMedGoogle Scholar
  • 25 Blum  A L, Talley N J, O'Morian C, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia (OCAY Study Group). .  New Engl J Med. 1998;  339 1875-1881
    CrossrefPubMedGoogle Scholar
  • 26 McColl  K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. .  New Engl J Med. 1998;  339 1869-1874
    CrossrefPubMedGoogle Scholar
  • 27 Meining A, Kiel G, Stolte M. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.  Aliment Pharmacol Ther. 1998;  12 735-740
    CrossrefPubMedGoogle Scholar
  • 28 Treiber G, Lambert J R. The impact of Helicobacter pylori eradication on peptic ulcer healing.  Am J Gastroenterol. 1998;  93 1080-1084
    CrossrefPubMedGoogle Scholar
  • 29 Neil G A, Suchower L J, Johnson E, et al. Helicobacter pylori eradication as a surrogate marker for the reduction of duodenal ulcer recurrence.  Aliment Pharmacol Ther. 1998;  12 619-633
    CrossrefPubMedGoogle Scholar
  • 30 Macri G, Milani S, Surrenti E, et al. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.  Am J Gastroenterol. 1998;  93 925-927
    CrossrefPubMedGoogle Scholar
  • 31 Tu T C, Lee C L, Wu C H, et al. Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers.  Gastrointest Endosc. 1999;  49 302-306
    PubMedGoogle Scholar
  • 32 Ciociola A A, McSorley D J, Turner K, et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated.  Am J Gastroenterol. 1999;  94 1834-1840
    CrossrefPubMedGoogle Scholar
  • 33 Lee Y T, Sung J J, Choi C L, et al. Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit?.  Am J Gastroenterol. 1998;  93 928-931
    CrossrefPubMedGoogle Scholar
  • 34 Iijima K, Ohara S, Sekine H, et al. A new endoscopic method of gastric acid secretory testing.  Am J Gastroenterol. 1998;  93 2113-2118
    CrossrefPubMedGoogle Scholar
  • 35 Hawkey  C J, Tulassay Z, Szczepanski L, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. .  Lancet. 1998;  352 1016-1021
    CrossrefPubMedGoogle Scholar
  • 36 Chan F K, Sung J J, Suen R, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug-associated bleeding peptic ulcers? A prospective randomized study.  Aliment Pharmacol Ther. 1998;  12 1201-1205
    CrossrefPubMedGoogle Scholar
  • 37 Hawkey C J. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance.  Aliment Pharmacol Ther. 1999;  13 695-702
    CrossrefPubMedGoogle Scholar
  • 38 Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.  Gastroenterology. 1999;  117 17-25
    PubMedGoogle Scholar
  • 39 Konturek J W, Konturek S J, Stachura J, Domschke W. Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin.  Aliment Pharmacol Ther. 1998;  12 857-864
    CrossrefPubMedGoogle Scholar
  • 40 Hirschowitz B I, Lanas A. Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer.  Gastroenterology. 1998;  114 883-892
    PubMedGoogle Scholar
  • 41 Lin B R, Shun C T, Wang T H, Lin J T. Endoscopic diagnosis of intestinal metaplasia of stomach: accuracy judged by histology.  Hepatogastroenterology. 1999;  46 162-166
    PubMedGoogle Scholar
  • 42 Driessen A, Ectors N, Creemers J, et al. Intestinal metaplasia in gastric malignancy: a comparison between carcinoma and lymphoma.  Eur J Gastroenterol Hepatol. 1998;  10 595-600
    PubMedGoogle Scholar
  • 43 Chang C S, Chen L T, Yang J C, et al. Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach.  Gastroenterology. 1999;  117 82-88
    PubMedGoogle Scholar
  • 44 Lind T, Mégraud F, Unge P, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.  Gastroenterology. 1999;  116 248-253
    CrossrefPubMedGoogle Scholar
  • 45 Malfertheiner P, Bayerdörffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer.  Aliment Pharmacol Ther. 1999;  13 703-712
    CrossrefPubMedGoogle Scholar
  • 46 Levin T R, Schmittdiel J A, Henning J M, et al. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization.  Am J Gastroenterol. 1998;  93 743-747
    CrossrefPubMedGoogle Scholar
  • 47 Juul K V, Thomsen O O, Nissen A, et al. National surveillance of Helicobacter pylori eradication therapy in Denmark: results from registration of 34 582 prescriptions.  Scand J Gastroenterol. 1998;  33 928-932
    CrossrefPubMedGoogle Scholar
  • 48 Stone M A, Patel H, Panja K K, et al. Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England.  Eur J Gastroenterol Hepatol. 1998;  10 957-962
    PubMedGoogle Scholar
  • 49 Fraser A G, Schreuder V, Chua L E, Moore L. Follow-up after successful eradication of Helicobacter pylori: symptoms and reinfection.  J Gastroenterol Hepatol. 1998;  13 555-559
    PubMedGoogle Scholar
  • 50 Gisbert J P, Pajares J M, Garcia-Valriberas R, et al. Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it.  Scand J Gastroenterol. 1998;  33 1144-1151
    CrossrefPubMedGoogle Scholar
  • 51 Graham D Y, Hepps K S, Ramirez F C, Lew G M, Saeed Z A. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.  Scand J Gastroenterol. 1993;  28 939-942
    PubMedGoogle Scholar
  • 52 Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.  Gastrointest Endosc. 1995;  41 1-4
    CrossrefPubMedGoogle Scholar
  • 53 Santander C, Gravalos R G, Cedenilla A G. Maintenance treatment vs. Helicobacter pylori therapy in preventing rebleeding of the peptic ulcer disease. A clinical trial and follow-up for two years (abstract).  Gastroenterology. 1995;  108 A208
    PubMedGoogle Scholar
  • 54 Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.  Digestion. 1994;  55 19-23
    PubMedGoogle Scholar
  • 55 Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar C H. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage.  Gastrointest Endosc. 1995;  41 5-7
    PubMedGoogle Scholar
  • 56 Salandin S, Dal Bo N, Grassi S A, Ferrana M, Kusstatscher S, Vianello F, et al. Eradication of H. pylori infection in preventing duodenal ulcer bleeding: one year interim report in a prospective five-year study (abstract).  Gut. 1996;  39 (Suppl. 2) A28
    PubMedGoogle Scholar
  • 57 Macri G, Milani S, Surrenti E, Passaleva M T, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.  Am J Gastroenterol. 1998;  93 925-927
    CrossrefPubMedGoogle Scholar
  • 58 Pazzi P, Dalla Libera M, La Froscia A, Carli G, Scagliarini R, Merighi A, et al. Helicobacter pylori eradication reduces rebleeding rate in peptic ulcer disease (abstract).  Gastroenterology. 1996;  110 A224
    PubMedGoogle Scholar
  • 59 Sung J J, Leung W K, Suen R, Leung V K, Chan F K, Ling T K, et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.  Dig Dis Sci. 1997;  42 2524-2528
    CrossrefPubMedGoogle Scholar

G.N. J. TytgatM.D. 

Dept. of Gastroenterology and Hepatology

Academic Medical Center

Meibergdreef 9

1105 AZ Amsterdam Zuidost

The Netherlands

Phone: + 31-20-566-9157

Email: g.n.tytgat@amc.uva.nl